cagrilintide retatrutide combination trial Updates in Medicine | π¬ REDEFINE 2: CagriSema in T2D + Obesity Original article link in bio π₯ Phase 3a RCT in 1206 adults with T2D (BMI β₯27, HbA1c 7β10%) π VisualAbstract: Combined cagrilintide and semaglutide
Description
Neben der Gewichtsreduktion und Verbesserung der glykmischen Kontrolle zeigen GLP-1-RA positive Effekte auf adipositasassoziierte Komorbiditten (z

As with any metabolic intervention, working with a knowledgeable practitioner is always preferable

At these microdoses, clients often report: Feeling comfortably full with smaller portions Fewer late-night snack cravings that can stall weight goals More stable, all-day energy without the highs and crashes Clearer focus and reduced brain fog Better control over emotional or stress-related eating Less day-to-day fluctuation in appetite Improved consistency with exercise routines due to steadier energy Feeling more in control of eating choices, rather than food controlling them Microdosing also makes it easier to integrate the medication into a whole-body wellness plan
Ideal candidates for peptide therapy at Relive Health West Nashville include athletes looking to improve recovery and boost endurance, individuals seeking to address age-related concerns like skin elasticity or muscle retention, and adults looking for support with energy and overall vitality

10.1038/s41564-021-00880-5 Nat
While still in trial, side effects reported have been similar to existing GLP-1 medications, typically mild gastrointestinal issues
